J. Antonio Lopez, MD, Cardiology, Newbury Park, CA

J. AntonioGLopezMDFACC,FAHA,FACP,FNLA, FASH, FASPC

Cardiology Newbury Park, CA

Echocardiography, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation, Cardiac Critical Care

Clinical Research Medical Director Cardiovascular and Cardiovascular Therapeutic Area Global Development Amgen

Dr. Lopez is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lopez's full profile

Already have an account?

Summary

  • J. Antonio G. López, MD, FACC, FAHA, FACP, FCCP, FASE, FNLA, FASH, FASPC
    J. Antonio G. López, MD, is Clinical Research Medical Director, Cardiovascular and Metabolic Therapeutic Area, Global Development at Amgen. He was most recently Cardiovascular Medical Director US Medical Organization and US Medical Organization CV Medical Advocacy Relations Lead at Amgen. He is a cardiologist, lipidologist, and hypertension specialist. Prior to joining Amgen in 2014, he was with Saint Alphonsus Medical Group Heart Care in Boise, Idaho. Dr. López was Director of Preventive Cardiology and CV Rehabilitation, Director of the Lipid Clinic, and Director of the LDL Apheresis Program at Saint Alphonsus Regional Medical Center in Boise, Idaho. He also served as Chair of Cardiology at Saint Alphonsus. In addition, he was Chair CV Research and Education, Director of the Hypertension Consultation Service and Director of the Carotid Intima-Media Thickness (CIMT) Program at Saint Alphonsus Medical Group Heart Care. His previous experience includes serving as Director of the Lipid Clinic and Director of CV Outpatient and Outreach Programs at the University of Iowa and Director of Cardiac Care and the Coronary Care Unit at the VA Medical Center in Iowa City, Iowa. He was also Medical Director of Preventive Cardiology, CV Rehabilitation, the Lipid Clinic and Prevention Center at the Prairie Heart Institute in Springfield, Illinois.
    Dr. López received his medical degree Cum Laude from Harvard Medical School. At Harvard, he received the Henry J. Kaiser Family Foundation Merit Scholar Award. He completed his residency in internal medicine at Cedars-Sinai Medical Center at the University of California, Los Angeles. He was a Research Fellow in the cardiac unit at the Massachusetts General Hospital. He went on to complete a fellowship in cardiovascular diseases and interventional cardiology in the Department of Internal Medicine at the University of Iowa Hospitals and Clinics in Iowa City.

Education & Training

  • U Iowa Hosps and ClinicsFellowship, 1986 - 1989
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Medicine, 1983 - 1986
  • Harvard Medical School
    Harvard Medical SchoolClass of 1983
  • Massachusetts Gen HospFellowship, Cardiac Unit, 1980 - 1981
  • University of California at San Diego
    University of California at San DiegoB.A, General Biology, Cum Laude, 1973 - 1978

Certifications & Licensure

  • ID State Medical License
    ID State Medical License 2007 - 2015
  • CA State Medical License
    CA State Medical License 1985 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Physician of the Year, Hispanic Health Leadership Award National Hispanic Medical Association (NHMA), 2018
  • Cardiovascular Medicine Distinguished Alumnus Award Division of Cardiovascular Medicine, The University of Iowa, 2018
  • Distinguished Alumnus Award for Achievement University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2018
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Nonbacterial Thrombotic Endocarditis (NBTE), A Review.  
    Lopez, J.A.G., Ross, R.S., Fishbein, M.C., and Siegel, R.J, Am. Heart J
  • What Causes Spasm of Atherosclerotic Arteries? Is Regression of Plaques Beneficial?  
    Heistad, D.D., Armstrong, M.L., and Lopez, J.A.G, Trans. Amer. Clin. Climatol. Assoc
  • Hemodynamic Determinants of Vascular Changes in Hypertension and Atherosclerosis.  
    Heistad, D.D., Lopez, J.A.G., and Baumbach, G.L, Hypertension
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Detection of Early Necrosis in Low Flow Myocardial Ischemia Using Antimyosin.
    Timmis, A.D., Lopez, J.A., J.T., Khaw, B.A., Haber, E., and Powell, W.J, Circulation
  • Neurogenic Vasoactive Properties of Ouabain.
    Lopez, J.A., Timmis, A.D., Garan, H., Homcy, C.S., and Powell, W.J, Circulation
  • Role for 125I-Antimyosin (Fab) 2 in Early Detection of Myocardial Necrosis.
    Timmis, A.D., Lopez, J.A., Fallon, J.T., Khaw, B.A., Haber, E., and Powell, W.J, Br. Heart J
  • Join now to see all

Lectures

  • Emerging Cardiac Risk Factors and Treatment: A Focus on CRP and Fish Oil. 
    Medical Grand Rounds, Annenberg Center for Health Sciences. Eisenhower Medical Center. Rancho Mirage
  • Optimizing LDL-Cholesterol Goal Achievement: An Evidenced Based Approach. 
    Multiple locations, 2007
  • Current Concepts and Management of Congestive Heart Failure. 
    California Hispanic American Medical Association, Los Angeles, California
  • Join now to see all

Other Languages

  • Spanish